Business Insider India🇮🇳 Profile picture
Intelligence for India's next generation. Sign up for BI's weekly newsletter - Simply Put: https://t.co/oxyGbK5LhO Subscribe on Telegram: https://t.co/pGmlGDzYbr

May 12, 2021, 15 tweets

#coronavirus: One chart shows how dramatically the pace of #vaccinations differs from country to country

businessinsider.in/science/news/o…

#coronavirusvaccine: Epidemiologists have estimated that countries will need to vaccinate around 75% of their populations to reach #herdimmunity - the threshold beyond which the #coronavirus can no longer spread easily from person to person.

For many nations, that's a far-off goal. At the current rate of 110,000 vaccinations per day, it could take Japan eight months to immunize just a quarter of its population, and more than two years to immunize 75%.

#coronavirusvaccine #VaccinationDrive #covid19 #coronavirus

By next week, around half the US population will have received at least one #coronavirus shot - a milestone that could take other countries years to reach at their current pace.

#coronavirusvaccine #covid19 #VaccinationDrive

The pace of #vaccinations across the globe remains highly uneven: As of Monday, wealthy countries had received 83% of the world's vaccine supply, despite making up just 53% of the world's population, according to @WHO director-general Tedros Adhanom Ghebreyesus.

Israel, the US, and the UK have the world's fastest vaccine rollouts so far. Israel vaccinated half its population in just two months, from December to February, while the UK reached that milestone two weeks ago. In roughly a month, around 75% of the UK could be vaccinated.

South Korea faces a similar predicament: The country's 75% vaccination threshold is more than a year away. That means it's likely to take years to reach herd immunity on a global scale.

#coronavirusvaccine #coronavirus #covid19 #VaccinationDrive

Early in the #pandemic, wealthy countries like the US and UK struck deals with pharmaceutical companies - before it was even known whether their vaccines were safe or effective - to buy enough doses for their residents.

#coronavirusvaccine #coronavirus #covid19 #VaccinationDrive

Lower-income countries couldn't afford to make that gamble, so many are still vying for shots or waiting on supply from nations that manufacture doses domestically, like China,Russia. But even some high- or middle-income nations have had slow vaccine rollouts.

#VaccinationDrive

Brazil, for instance, rejected an offer to purchase 70 million doses of Pfizer's vaccine in August, instead betting on AstraZeneca's shot (which is significantly cheaper) to drive its vaccination efforts.

#coronavirusvaccine #coronavirus #covid19 #VaccinationDrive

But Brazil is now running low on vaccine supply, so it's relying on backup doses of China's Sinovac shot.

#coronavirusvaccine #coronavirus #covid19

Language from Brazilian President Jair Bolsonaro has also fueled vaccine skepticism. Bolsonaro previously joked that the Pfizer shot could "turn you into an alligator."

#coronavirusvaccine #coronavirus #covid19

#Vaccination: In Japan and South Korea, some public-health experts have attributed slow rollouts to consistently low caseloads: Japan's daily #coronavirus cases have never exceeded 8,000, and South Korea's daily cases have stayed below 1,000 for most of the #pandemic.

Only doctors and nurses are allowed to administer shots in Japan, and the nation didn't authorize its first #coronavirusvaccine until February, months after the #US and #UK.

#coronavirus #Vaccination

India has also lagged behind in delivering vaccines to the public. Its #VaccinationDrive took a hit when cases began to skyrocket in Feb, amid the spread of new variants. Healthcare workers had to shift their focus away from administering shots to care for hospitalized patients.

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling